In the past 50 years, only one new tuberculosis drug has come on to the market, yet many more active substances are urgently needed.
Current treatments increasingly fail due to multidrug-resistant pathogens. ETH researchers have now applied to patent a novel approach for developing new tuberculosis drugs.
Consumption was one of the worst known diseases of the 18th century. Thanks to medical advances, the number of deaths from this lung disease – which is today known as tuberculosis – has declined significantly. Efforts to eradicate the disease in the 1950s and 1960s resulted in a wide range of new drugs entering the market.
And yet 1.4 million people still continue to die each year from tuberculosis. Multidrug-resistant strains of the disease-causing pathogen are especially dangerous because they can no longer be treated with today’s drugs (see box). “In the past 50 years, only one new tuberculosis drug has come on to the market, and that was in 2012,” says Karl-Heinz Altmann, Professor of Pharmaceutical Biology at ETH Zurich. New active substances that are able to kill multidrug-resistant strains of the disease are therefore urgently needed. Altmann and his team have now laid the foundation for new tuberculosis drugs, and they were inspired by a bacteria-derived antibiotic called pyridomycin.
The Latest on: Tuberculosis drugs
via Google News
The Latest on: Tuberculosis drugs
- Treating tuberculosis in Ukraineon June 3, 2020 at 6:41 am
The man, Nikolai, is a patient at the tuberculosis (TB) treatment centre in Donetsk, Ukraine. Formerly a Soviet centre for steel production and coal dismantling, life in Donetsk has steadily become ...
- Personal Stories from TB Survivors - My Journey fighting TBon June 3, 2020 at 1:27 am
These are the stories of TB survivors from around the world on their journey fighting and beating TB. These survivors have experienced the side effects of TB medication, the difficulties of undergoing ...
- Cases touch 2L, now TB machines for testson June 2, 2020 at 6:38 pm
As Covid caseload touched the two lakh mark today, the Indian Council of Medical Research gave its nod for the use of TB detection machines for confirmation of the disease.
- 20% of annual sales as incentive for import substitution of bulk drugs, devices from Chinaon June 2, 2020 at 2:10 am
Bulk drugs and intermediates that will be covered under the scheme are meant to produce vitamins, anti-TB drugs, anti-infectives, antibiotics, steroids, etc. According to official sources, the scheme, ...
- Cambodia: 'War on Drugs' is rife with torture, corruption and on brink of triggering a COVID-19 catastrophe - New Reporton June 1, 2020 at 2:49 pm
We are Amnesty International UK. We are ordinary people from across the world standing up for humanity and human rights.
- Lockdown worsens plight of HIV, tuberculosis patientson June 1, 2020 at 3:54 am
Some of the people living with HIV/Aids and Tuberculosis cannot access hospitals due to transport, stigma and hunger.
- UN agencies call for closure of drug detention centers amid COVID-19 pandemicon May 31, 2020 at 10:08 pm
"Among the groups particularly at risk of contracting the virus are people in compulsory drug detention and rehabilitation centers. They are often comprised of people who are suspected of using drugs ...
- “India Needs To Talk About Mental Health And COVID-19, HIV And TB”on May 27, 2020 at 2:13 pm
TB and HIV come with a host of mental health issues which can affect one’s quality of life, and should be addressed.
- Coronavirus hampers Africa's fight against malaria, TBon May 27, 2020 at 6:41 am
As early as February - when the coronavirus outbreak was still almost exclusively restricted to China –experts were raising the alarm: Once the virus arrived in Africa, the continent's poor healthcare ...
- Tuberculosis Testing Market Analysis as per the Latest COVID-19 Impacton May 26, 2020 at 4:38 am
You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions. The Tuberculosis ...
via Bing News